Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL003062

Drug Information
NameVortioxetine
CompanyLundbeck;Takeda Pharmaceuticals U.S.A.
IndicationAnxiety disorders (pediatric)
[ICD9: 300   ICD10: F40-F42]
Phase II    
Depressive disorders (pediatric)
[ICD9: 296   ICD10: F30-F39]
Phase II    
Generalized anxiety disorder
[ICD9: 300.02   ICD10: F41.1]
Phase III    
Generalized anxiety disorder (see also depression)
[ICD9: 300, 300.02, 311   ICD10: F32, F40-F42, F41.1]
Phase III    
Major depressive disorder
[ICD9: 296.2, 296.3   ICD10: F32, F33]
Filed    
Major depressive disorder (see also anxiety)
[ICD9: 296.2, 296.3, 300   ICD10: F32, F33, F40-F42]
Phase III    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-
19-10-12-20/h3-8,13,19H,9-12H2,1-2H3
InChIKeyYQNWZWMKLDQSAC-UHFFFAOYSA-N
Canonical SMILESCC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C    
CAS NumberCAS 508233-74-7
FormulaC18H22N2S
PubChem Compound IDCID 9966051.
SuperDrug ATC IDN06AX26



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543